Caffeine-based Compounds Show Promise Against Parkinson's Disease
Compounds prevent key protein from mis-folding, preventing death of dopamine-producing brain cells
A teem of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson’s disease.
Parkinson’s disease attacks the nervous system, causing uncontrolled shakes, muscle stiffness and slow, imprecise movement, chiefly in middle-aged and elderly people. It is caused by the loss of brain cells (neurons) that produce dopamine, an essential neurotransmitter that allows neurons to “talk” to each other. The team focused on a protein called a-synuclein (AS), which is involved in dopamine regulation.
Click here to read more.
Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland
12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans
2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.
Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany
Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.